What is the recommended rate of drop in Blood Urea Nitrogen (BUN) levels over 24 hours during Continuous Renal Replacement Therapy (CRRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Rate of BUN Drop During CRRT

There is no specific recommended rate of BUN drop over 24 hours during CRRT; instead, focus on achieving a target steady-state BUN level of 40-80 mg/dL by delivering adequate CRRT intensity of 20-25 mL/kg/hr, which will naturally result in BUN declining exponentially over 3-4 days to reach plateau. 1

Understanding BUN Kinetics During CRRT

The key concept is that BUN does not drop at a fixed rate per 24 hours. Instead, when CRRT is initiated at a constant intensity in patients with relatively stable urea generation rates, BUN falls in an exponential fashion, approaching a plateau level after 3-4 days of continuous treatment 2. The rate of decline is steepest initially and gradually slows as it approaches the steady-state target.

Target BUN Levels Rather Than Rate of Change

  • The goal is to achieve and maintain a steady-state BUN of 40-80 mg/dL, not to control the speed of decline 2
  • The CRRT clearance (K) necessary to achieve a desired plateau BUN can be calculated as: K = G/BUN_goal, where G is the urea generation rate 2
  • For a target BUN of 60 mg/dL with moderate hypercatabolism, a practical formula is: K (L/hr) = 2 × body weight (kg) / 100 2

Recommended CRRT Intensity to Control Uremia

Deliver a minimum effluent flow rate of 20-25 mL/kg/hr to adequately control uremia and achieve target BUN levels. 1

Evidence-Based Dosing Thresholds

  • The lower limit of delivered intensity to control uremia is approximately 10-15 mL/kg/hr, below which BUN and creatinine levels will continue to rise rather than decline 3
  • A prescribed intensity of approximately 15 mL/kg/hr may be adequate to prevent uremia progression, but higher doses are recommended for optimal outcomes 3
  • Intensities of 20-25 mL/kg/hr are recommended based on large randomized trials showing no benefit from higher doses (35-40 mL/kg/hr) 1

Accounting for Delivered vs. Prescribed Dose

  • Prescribed dose should be 20-25% higher than target dose to account for treatment interruptions and filter efficiency decline 1
  • In clinical practice, patients typically receive only 68-85% of prescribed dose due to circuit clotting, imaging, surgery, and declining membrane porosity 1
  • Monitor delivered dose rather than relying solely on prescribed settings 1

Monitoring BUN During CRRT

Frequency of Monitoring

  • Check BUN levels every 6-12 hours initially to assess response to therapy 4
  • BUN measurements should be interpreted in the context of their rate of change over time, not as isolated values 1
  • Rapid increases in BUN suggest severe renal dysfunction or inadequate CRRT intensity 1

Relationship Between BUN and Nitrogen Balance

  • BUN correlates strongly with nitrogen loss (r = 0.804, P < 0.0001) during CRRT 5
  • Median nitrogen loss during CRRT is approximately 10.6 g/day, with total nitrogen loss potentially reaching 25 g/day 1, 5
  • Higher protein intake (1.5-2.5 g/kg/day) increases BUN production, requiring adjustment of CRRT intensity to maintain target BUN levels 1

Common Pitfalls and Caveats

Avoid Overly Aggressive BUN Reduction

  • Do not aim for rapid normalization of BUN - the exponential decline over 3-4 days is physiologically appropriate 2
  • Excessively high CRRT intensities (>35-40 mL/kg/hr) do not improve outcomes and increase costs 1

Consider Urea Generation Rate

  • Urea generation rate (G) varies widely in critically ill patients and affects BUN trajectory 4
  • Normalized protein catabolic rate ranges from 1.2-2.1 g/kg/day in AKI patients on CRRT, with mean values around 1.75 g/kg/day 1, 4
  • Patients receiving higher protein intake (2.5 g/kg/day) require increased CRRT dose to manage elevated BUN production 1

Account for Residual Kidney Function

  • Residual kidney function contributes to urea clearance and should be factored into total clearance calculations 1
  • Urine output and urinary urea nitrogen should be measured when present 4

Special Consideration for Hyperammonemia

  • In hyperammonemia cases, aim for 50% reduction in ammonia within 4-5 hours using CVVHD, though this applies to ammonia rather than BUN specifically 1, 6
  • Continue CRRT until ammonia levels are <200 μmol/L on consecutive measurements 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urea kinetic modeling for CRRT.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997

Research

Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998

Guideline

Treatment of Hyperammonemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended daily drop in Blood Urea Nitrogen (BUN) during Continuous Renal Replacement Therapy (CRRT)?
What does a significant drop in Blood Urea Nitrogen (BUN) from 117 to 35 within 24 hours indicate in an Intensive Care Unit (ICU) patient undergoing Continuous Renal Replacement Therapy (CRRT)?
What is the target Blood Urea Nitrogen (BUN) level after 24 hours of Continuous Renal Replacement Therapy (CRRT) if the initial BUN is 117 mg/dL?
What is the recommended approach for managing dialysis in patients with impaired renal function in the neurocritical care setting?
What is the estimated creatinine clearance for dosing medication in a patient on Continuous Renal Replacement Therapy (CRRT)?
Is a diagnosis of retroorbital pseudotumor (idiopathic orbital inflammatory disease) likely in a 19-year-old female with left eye swelling, chronic inflammation in the lacrimal gland, focal fibrosis in the orbital fat, positive Antinuclear Antibody (ANA), negative Anti-Neutrophil Cytoplasmic Antibody (ANCA), and normal Immunoglobulin G4 (IgG4) levels?
What are the anesthetic considerations for a patient with an old lacunar infarct in the left capsulohanglionic region undergoing surgery under spinal (regional) anesthesia?
What is the treatment for eosinophilic esophagitis according to the American Gastroenterological Association (AGA) and American College of Gastroenterology (ACG)?
What tests are used to diagnose von Willebrand (vWD) disease?
What is the next step in treating cerumen (earwax) impaction?
How are venlafaxine (Effexor) withdrawal symptoms managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.